Translating Preclinical Insights to Clinical Success for a First-in-Class T-Cell Engager
- Prediction of efficacious concentrations using translational PK/PD modelling
- Optimizing clinical delivery and safety with the use of step-up dosing
- Utilize potential biomarkers